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Introduction
Over a century has gone since the first spinal anesthesia 
on humans was realized, but the difficulty to guarantee a 
satisfactory subarachnoid block, in extension and in inten-
sity, remains; the dispersion of local anesthetics into the 
cerebrospinal fluid, as described by August Bier (1), remains 
“capriciousness”.
 The effectiveness of a spinal anesthesia,  the intensity 
of the block and the diffusion of the local anesthetic cannot 
depend on the physiologic composition of the cerebrospinal 
fluid (CSF) and on the pharmacokinetic and pharmacody-
namic properties of the drug selected.
During the 80s and the 90s many studies examined the 
responsible factors for the interindividual variability when 
the dispersion of iso-hypobaric anesthetics and intensity 
of sensory-motor block happen (2) It can depend on their 
characteristics, but also on the liquor one’s (3,4).
CSF and Individuals factors may influence the behavior 
of iso-hypobaric anesthetics within the subarachnoid space; 
clinical studies tried to attribute to  single factors the varia-
bility in intrathecal drug’s dispersion. Nowadays,  no study 
proved a multi-factorial close correlation  with  the CSF 
composition, to predict the local anesthetic’s effect. 
The patient’s position influences the intrathecal diffu-
sion of the hyperbaric anesthetics (5); the metameric level 
obtained with the isobaric solutions is unpredictable (6) 
and little influenced by the position (7,8); however, the 
considerable interindividual variability of the block still 
remains controversial.
There are many factors  patient dependent  like  the  ane-
sthetic diffusion,  the injection’s technique and the injected 
solution (9,10).  
The CSF is a clear, transparent, and uncoagulable liquid, 
with a specific weight between 1002 to 1010 (at 37° C  ave-
rage value is 1003), higher in the spinal cord, because of 
the high level of proteins. The density of CSF depends on 
the NaCl content,  temperature, protein and carbohydrate 
concentration; it increases in the elderly, in the lower spi-
ne’s region, during pathological conditions that alter the 
qualitative composition  as hyperazotaemia, hyperglycemia, 
hypoproteinemia, hyperbilirubinemia, or hyperthermia.
The higher spinal cord density is an important factor that 
can interfere with the cranial spread of  local anesthetics.
Compared to plasma, liquor contains less protein (15-45 
mg / dl) and glucose (45-80 mg / dl), the pH is slightly acid 
(7.32 to 7.34),  because of the greater CO2 pressure (pCO2 
48 mmHg) and the lower bicarbonate’s level.  
Abstract
Background. Identify if glycorrhachia and cerebrospinal fluid pro-
tein  could influence the time of sensory block to T10, the duration and 
the metameric block's level, after a standard dose of Ropivacaine.
Methods. 80 patients, ASA I - III undergoing to transurethral 
prostate resection with spinal anesthesia in a prospected open study 
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The cerebrospinal fluid’s pressure in lateral decubitus 
varies from 9 to 20 cm H2O, between  37.5 to 50 cm H2O 
in a sitting position.
This pressure’s variation depends on age (increases with 
age), intracranial venous pressure (with higher values of 40-
50 mm H2O compared to the latter), pulmonary ventilation 
(oscillations of 4-10 mm H2O with breaths) and heart rate 
(ranging from 2-5 mm H2O) (11).
The glycorrhachia (n.v. 40 to 80 mg / dL) has plasma-
origins and corresponds to 2/3 of glycemia. The glycor-
rhachia is considered pathological when the glucose level 
decreases (less than 60%) in comparison with the plasma 
glucose, typical  of  the meningeal disease or intracranial 
neoplasia.
Increased values of glycorrhachia is very common in dia-
betics and when patients  are taking glucose solutions (12).
The CSF protein (n.v. 15 to 45 mg / dl) varies with 
age and the metameric sample level, higher in elderly and 
lumbar subarachnoid space, where the proteinorrachia is 
25-50 mg / dl.
The brain proteins derived both from the CSF and pla-
sma; the plasma concentration corresponds to 4/5 (70-80%) 
of total protein with a 55% of albumin, after passive filtration 
from the plasma. The remaining 1/5 (20-30%) is synthesized 
in the central nervous system (CNS).
 CSF protein  increases when meningitis, spinal tumors 
and serious bleeding are present, when the barrier damage 
occurs, with increased passage of proteins from plasma to 
CSF (13).
Ropivacaine was introduced in clinical practice in 1996; 
only in February 2004 the intrathecal administration (14,15) 
was approved by European Union.
The ropivacaine hydrochloride monohydrate is a long-
life local anesthetic (16), pH 6, belonging to the amide type, 
99.5% as the S-isomer (17,18).
 Kristensen et al (19), first documented the  safety of ropi-
vacaine in the subarachnoid space. Rosemberg and Heinonen 
in 1983 (20), by isolating the vagus and phrenic nerves on 
mice, show that ropivacaine at low concentrations (25-50 
micromol / l),   produces a rapid and profound block both of 
Aδ and C fibers without motor block. At higher concentra-
tions sensory and motor block  become equivalent.
According Wildsmith et al (21,) the C fibers block is 
faster than A ones, while low pKa and high lipid solubil-
ity  enhances A fibers  block. The magnitude of the block, 
frequency-dependent,  depends on the lipid solubility, the 
local anesthetic’s molecular weight and fiber’s diameter. 
The lower lipid solubility of ropivacaine, compared to bupi-
vacaine,  could be responsible for the slower diffusion of 
the anesthetic through the myelin sheath of the large motor 
fibers, being more selective for the autonomic and sensory 
nerve fibers, easier and markedly blocked (22,23).
The best block’s level  with ropivacaine at low concen-
trations and the possibility of determining a frequency-
dependent block, determine clinical advantages, especially 
in terms of reduced haemodynamic effects, better control of 
postoperative analgesia and faster recovery times (24).
Ropivacaine 0.5% at 23° C is considered an isobaric 
local anesthetic, with a density of 1.00380 (3DS) while at 
37° C becomes slightly hypobaric with a density  of 0.99953 
(3DS).
The metameric level of analgesia after subarachnoid 
anesthesia with Ropivacaine hydrochloride 0.5% is a little 
bit predictable.
 The factors that regulate the CSF dispersion of the local 
anesthetics is the question that supports a lively scientific 
discussion.
Among different mechanisms that influence the sensory 
block extension, we can include: the injection’s technique 
(lumbar interspace, patient position, needle tip direction 
and infusion rate), the anesthetic solution (volume, density, 
baricity, concentration and temperature), as well the CSF 
physico-chemical characteristics (CSF pressure, density, 
glycorrhachia, CFS protein, CSF volume, pH changes, tem-
perature) and patient’s characteristics (age, BMI, metabolic 
disorders).
The density of CSF, compared to the local anesthetic one, 
influences its distribution in the subarachnoid space.
Background
The purpose of the study was to identify if CSF phys-
iochemical characteristics (glycorrhachia and CFS protein) 
could influence the time of sensory block to T10, the dura-
tion and the metameric level of the block, after a intrathecal 
standard dose of Ropivacaine hydrochloride 0.5% 15 mg. 
When these two parameters interact  subarachnoid block, a 
quick concentration test might be useful for the quantifica-
tion of the local anesthetic to be administered.
Methods
80 patients, ASA I-III, undergoing to transurethral 
prostate resection (TURP)  were recruited for a prospectic, 
open, unicenter study. After obtaining the informed consent, 
data on sex, age, weight, height, BMI (kg / m2) and fasting 
plasma glucose  (FPG) were collected (Table 1).
Blood sugar, one hour before the surgical procedure, 
was tested in all patients;  intraoperative analgesia, through 
a lumbar spinal anesthesia, was  obtained. 
Exclusion criteria were related to bleeding disorders, a 
history of headache, injection site infection, neurodegenera-
tive diseases, known allergy to amide local anesthetics  or 
anesthetic procedure  denial.
Vital parameters of each patient (SaO2, NIBP, FC, ECG) 
were monitored; premedication with midazolam 0.02 mg / 
kg i.v. and i.v. infusion with 500 ml NaCl 0.9% were ad-
ministred. Body and anesthetic solution’s temperatures (°C) 
were noticed through a thermal sensor;  in the case of local 
anesthetic, the probe was introduced into a vial of the same 
package, used as a sample. The patient was sitting on the 
operating table and, after threefold skin disinfection  and the 
Age   71,07 ±7,45  (46-88)
Weight (Kg)    78,98 ±13,66 (46-110)
Height   (cm)       171±7,56  (150-187)
BMI (Kg/m2)                   26,73 ±4,23  (18-41)
ASA I/II/III                                            6/35/39
Table 1.Cases - Mean ± SD (range).
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local infiltration of subcutaneous tissue with lidocaine 2% 3 
mL, spinal anesthesia at L3-L4 with Whitacre needle (25 G) 
was performed. A 0.2 ml liquor’s sample was taken; glycor-
rhachia, by glycemic stix (Bayer-2- BREEZE® reaction by 
the enzyme glucose oxidase) in 5 seconds, while the CSF 
protein, urinary density stick (YerconTM- URS-10), in 60 
seconds,  were got. Ropivacaine 0.5% 15 mg were injected, 
without neither barbottage nor aspiration and mixing the 
local anesthetic with CSF, in an average time between 20 
and 30 sec (0,15- 0.10 ml / sec).
Thereafter, all patients were positioned in anti-trende-
lemburg, with 30 ° tilting for 15 min.
The onset of sensory block to T10, the maximum meta-
meric level to 15’ and the period of sensory block were 
reported.
The data collection were analyzed using the software 
language R. Relationship between the variables were high-
lighted by  the simple regression model, Y = α + βx + ε, 
which expresses the linear relationship between the variable 
X (independent variable) and the variable Y (dependent 
variable), while α represents the intercepta, β the angular 
coefficent and ε the difference. The Pearson correlation co-
efficient (rho) was used to express any reports of linearity 
between the variables analyzed, considering them from -1 
(negative correlation) and +1 (positive correlation); A value 
of 0 indicates no correlation. The determination coefficient 
R2 (or correctness of model adaptation to the data) was 
used to evaluate the linear relationship probability, ie,  the 
variability ratio of Y. Its value ranges from 0 (no adaptation) 
and 1 (perfect fit).
Data were rendered as mean, standard deviation and 
range (difference between the maximum and minimum). A 
P-value <0.05 was considered significant.
Results
The following observational study involved 80 pts, 25 
females (31.3%) and 55 males (68.7%), matched for age, 
weight, height, BMI and ASA, undergoing TURP surgery.
Routine glycemia, preoperative FPG and body tempera-
ture were reported (Table 2).
Glycorrhachia, CSF protein and specific weight were 
tested in the liquor sample; Onset  T10, maximum dermato-
mal level block and sensitivity normalizing were evaluated 
after the local anesthetic injection (Table 3).
Table 3. Parameters - mean ± SD (range).
 
Glycor-
rachia
CSF
pro-
tein
Spe-
cific 
weight
Block
 level
Onset
T10
Sensi-
tivity
Media 69,16 22,31 1,0100 8,56 9,80 183,33
DS 16,30 7,54 0,0041 1,56 4,71 33,99
Min 46,00 15,00 1,0050 6,00 2,06 90,00
Max 105,00 30,00 1,0150 10,00 20,00 250,00
Statistical analysis evidenced a significant correlation 
(rho) between the liquor specific weight and the preoperative 
glycemia equal to 0.749, i.e. 75%. Statistically significant 
correlations resulted between the liquoral specific weight 
and glycorrhachia (rho = 0.751; R2 = 0.564; P-value <0.05); 
between the specific weight and CSF protein (rho = 0.684; 
R2 = 0.468 ; P-value <0.05). The correlation between CSF 
weight and maximum range of sensory block showed an 
inverse relation with values of rho -0.789 and P-value <0.05, 
but, simultaneously, with an R2 of 0.621. The correlation 
between the specific weight and ΔT (the difference between 
body temperature and anesthetic temperature) was low, with 
values of 16% Table 4 and Figure 1-4.
Table 4. The parameter specific weight has been correlated 
respectively with preoperative blood glucose, glycorrhachia, CSF 
protein, dermatomal maximum range of the block and difference 
in temperature between the body and of the anesthetic. Statistical 
indices evaluated: rho, R2, p-value.
Specific 
weight
Preop
glycemia
Glycor-
rachia
CSF 
Protein
Max range
block
  ΔT
rho 0,749 0,751 0,684 -0,788 0,156
R-squared 0,538 0,564 0,468  0,621 0,013
P-value 8,41E-53 1,04E-12 2,70E-09 <2,2E-16 1,52E-14
FPG (mg/dl)  99,4 ±31,5 ( 50-180)
Preoperatory FPG (mg/dl) 91,2± 20,6 (51-140)
Body Temperature (°C)    36,05 ±0,4 (35-37)
Table 2. Parameters - Mean ± SD (range).
Fig 1. Report PS-glycorrhachia 
174
                                               S. Collini et al.
    
Fig.2. Report PS-maximum extension block
Fig. 3. Report PS-proteinorrachia                                                       
Fig. 4. Report PS –ΔT
The study further investigated the correlation between 
the onset time to T10 of Ropivacaine 0.5% and glycorra-
chia,  the cephalic block’s level and glycorrachia.  We got 
an inverse relation,  corresponding to 84% in the first case 
and 76% in the latter (Table 5). The correlation glycorrha-
chia - cephalic level of the block, was also evaluated in (29) 
(36,25%) diabetic case patients, resulting weakly positive 
with a value of 33%.
The onset time to T10  and the cephalad block with CSF 
protein  were compared, with an inversely correlation in both 
cases,  respectively 84% and 67% (Table 5).
Correlations BMI - onset at T10 evidenced a rho of - 
0.712 with an R2 of 51%;  relationship  BMI - maximum 
cephalic block showed a rho of 0.681 with an R2 of 46%. The 
perfect adaptation is considered good,  51% in the first case 
and  46% in the second. Both correlations were statistically 
significant with values of P-value <0.05 (Table 6).
Rho GLYCORRACHIA
ONSET to T10 -0,836
MAX CEPHALIC BLOCK
MAX CEPHALIC BLOCK DIABETIC PT.       -0,756
0,328
 
Rho CSF PROTEIN
ONSET to T10 -0,81
MAX CEPHALIC BLOCK -0,661
Table 5. Correlation between onset to T10- glycorrhachia; cephalic 
level of the block (in diabetic and not) -gyicorrachia; onset time to 
T10-CSF protein; cephalic  levelc-CSF protein.
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Similarly, a correlation between body mass index and 
cephalic block in 18 (22.5%) obese patients (BMI > 30) 
was considered. Inversely relationship of 38%,  with a low 
value of R2 (15%) and a P-value statistically significant 
resulted (Table 7).
The time of sensibility recovery  can decrease with  incre-
asing of glycorrhachia, with a correlation coefficient of 71%, 
51% of capacity adaptation and increases with the (CSF 
protein). The time to reversal of sensibility get longer, even 
when a  major cephalic block was obtained (Table 8).
Discussion
Spinal anesthesia remains a reference tecnique, while 
the pharmacokinetics of local anesthetics, whether iso-
hypobaric or hyperbaric, administered intrathecally, is still 
a matter of intense discussion (25-28).
Malinovsky et al (29) evaluated an intrathecal injection 
of isobaric ropivacaine (15 mg) for urologic endoscopic 
surgery and found that inadequate spinal anesthesia occurred 
in 16% of  patients. 
The difficulty to predict the maximum level of sensory 
block would depend from different inter-individual parame-
ters, that influences the intrathecal dispersion, unpredictable 
both in extent (30)  and duration (31).
Baricity, defined as the ratio between density local 
anesthetic and cerebrospinal fluid, is considered the factor 
limiting the distribution of anesthetic in terms of diffusion 
and metameric level (32,33).
Decubitus, determines the local anesthetics spread in the 
CSF: the hyperbaric solutions spread caudally,  while hypo-
baric cranially. Moreover, gravity should not have important 
effects on the isobaric anesthetic spread.
A few studies (34) evaluated the CSF density in relation 
to the patient’s characteristics  (low number of individuals 
enrolled, neurological abnormalities, and diseases such as 
diabetes) (35). The temperature influences the CSF density, 
introducing an additional element of variability (36): the 
density of all anesthetic solutions “glucose-free” decreases 
to 0.0003 mg / ml for each temperature increase of 1° C 
of between 23 and 37° C. Differences of 0.0006 mg / ml 
can influence the  anesthetic spread (37).  According to 
Young Chang (38), warming up reduces the viscosity of 
the anesthetic not the anesthetic’s density. The high affinity 
of carbohydrates for water molecules, reduces the physio-
logical movements (39) within the CSF; this effect could 
explain the failure to density changing in the temperature 
range tested. The lower the viscosity of the injected solution, 
the higher is the level of analgesic block achieved (40); no 
correlation between temperature variation and onset time 
was evidenced.
In diabetic patients, the body temperature rises due to 
autonomic disorders (41), determined an higher level block 
for every increasing of 0.15 °C (42).
The sample analyzed of 80 patients contained 29 
(36.25%) diabetics; no significant changes in body tempera-
ture compared with 51 not diabetics (76.8%) were evidenced, 
nor increase of sensory block .
The correlation between the CSF weight  and the tem-
perature (ΔT) in diabetic patients was only 15%.
Ann et al (43,44), found negative correlation between the 
glucose concentration and density while they found positive 
correlation  between CSF protein and density. 
Otherwise, Harold Davis (45) reported that water, 
sodium, chlorine, CO2 less than 1/4 and protein less than 
1/5 influence CSF density. In abnormal conditions urea, 
glucose and temperature interfere with density. Davis be-
lieves that temperature, more than proteins, interacts with 
density (46).
However, glycorrhachia and  CSF protein are likely the 
factors determining the density of CSF; both show a positive 
correlation respectively by 75% and 68%.  A similar corre-
lation (rho = 75%) between preoperative density and CSF 
glucose was observed, confirming the direct relationship 
between blood glucose level and glycorrhachia.
The study conducted by Schiffer (47), showed that the 
correlation between the maximum level of sensory block and 
CSF density appeared highly significant (p = 0.0004), but 
little predictive (R2 = 0.37), because of the inter-individual 
variables; CSF density is only one of the factors influencing 
the block’s level.
Our study shows an opposite correlation between CSF 
density and maximum cephalic block extension, with a pre-
dictivity  index of 0.621 and P-value <0.05; similar results 
were found by correlating glycorrhachia and maximum 
 
 ONSET to  T10           MAX CEPHALIC 
  BLOCK
BMI  
Rho -0,712 -0,681
R-Squared 0,506 0,46
P-value 1,36E-10 3,57E-09
Table 6. Correlation between BMI-onset time to T10 and cephalic 
extension of the block.
Table 7. Statistical correlation between obese patients and cephalic 
block.
 MAX CEPHALIC BLOCK
BMI (>30 Kg/m2) 
Rho -0,382
R-squared 0,145
P-value 6,65E-05
Table 8. Statistical correlation between time to reversal of sensibility 
-  glycorrhachia - CSF protein -  cephalic block.
GLYCORRA-
CHIA
CSF 
PROTEIN
CEPHALIC 
BLOCK
TIME TO 
SENSIBILITY
Rho -0,713 0,588 0,768
R-squared 0,508 0,346  0,589
P-value 1,21E-10 9,54E-06 <2,2E-16
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extension cephalic block.
 Between 2004 and 2006 Hideyuki (48) and Sanchez 
et al (49), identified a positive correlation between the 
maximum extension of sensory block and the level of CSF 
glucose concentration (r = 0.50, p <0.01). In our study, the 
limited block over T10, was related both to the volume of 
local anesthetic used ((Ropivacaine 0.5% 3 ml) ) and the 
patient’s position.
Intrathecal Ropivacaine 0.5% 15 mg, is the average 
dosage for lower abdomen, pelvis and lower limbs surgery. 
This volume secures an adequate sensory block, limits the 
extension cephalic block over T10, a potential safety factor 
for reduced cardiovascular adverse events. 
The maintenance after spinal anesthesia of anti-Trende-
lenburg 30° for 15 min, evidenced limited  anesthetic spread 
for all patients.
However, a weak positive correlation between glycorra-
chia and  maximum block extension in 29 diabetic patients, 
18 (62%) of them obese,  like the correlation between gly-
corrachia and CSF density were  reported (Table 8). It could 
be hypotesized that ropivacaine takes the characteristics of 
hypobaric anesthetic or that dural sac compression, typical 
of obese patients, could determine the rising of anesthetic 
in 18 patients with BMI> 30 m2 / Kg. The increased CSF 
glucose influences onset time to T10 (rho = -0.836), redu-
cing it (Table 5).
In 2008 Echevarria et al (50), thought that CSF glucose 
in diabetics could influence the outcome of spinal anesthe-
sia; for this reason  they divided two groups of 88 patients. 
No differences were reported in the maximum extension of 
sensory block, while the onset time was faster.  Moreover, 
the time to sensibility was protracted in diabetic patients. 
Richardson (51) and Schiffer (52), observed a reduced 
volume in the lumbar CSF in diabetics. Differently, Nassel 
(53) thought that CSF glucose increases  CSF water volume. 
The CSF volume controls the level and duration of sensory 
block but not the onset (54).
The anesthesia level is related to glycorrachia (55); the 
greater the concentration of glucose in CSF, the greater is the 
cephalad spread of local anesthetic, regardless of ropivacaine 
dosage and patient’s position.
Tao Xu et al (56) investigated the ED (50) of intrathecal 
isobaric and hyperbaric ropivacaine, by up-down sequential 
analysis in the patients undergoing knee arthroscopy and 
concluded that the ED50 values of hyperbaric ropivacaine 
and isobaric ropivacaine were 6.55 mg (95% CI 6.07-7.04) 
and 9.71 mg (95% CI 8.11-11.32), respectively. The pre-
sence of higher levels of liquoral’s glucose could change 
the density of ropivacaine, changing the onset time and the 
cephalad spread.
Several clinical trials (57,58) investigated for some pos-
sible correlation between BMI and maximum anesthetic’s 
cephalic extension.
The body mass index (BMI), showed a low predictive 
value (R2 = 0.5) (59), evidencing only partial clinical si-
gnificance for the local anesthetic spread. The great obese 
patient, highlights a cephalic anesthetic spread, a rapid 
onset time to T10 and a faster recovery of sensitivity, when 
compared with normal-weight patients (60). In our study, 
18 (22.5%) obese patients showed a faster onset time to T10 
than 62 (77.5%)  normal-weight patients (5.44 ± 2.28 min 
vs 11.63 ± 4.2 min).
Nuria (61), identified the glycorrhachia as an important 
factor that predicts the time to sensitivity; the glucose kinetic 
is the same for bupivacaine and lidocaine (62,63). Schiffer 
et al (64) found an inverse correlation between maximum 
extension of the block and duration; the higher the block 
level, the shorter its lifetime will be. Our results show that 
higher concentration of CSF glucose, corresponds  to a 
shorter sensory-motor duration  block (rho: -7.13; R2: 0.51; 
P-value <0.05).
CSF is the “solvent” of local anesthetics, its physical-
chemical characteristics influence the distribution and the 
block’s duration.
Nuria (47) and Nassel (54) believe than an increased 
volume of CSF water determines a dilution of anesthetic 
solution, reducing the duration of the block, but increasing 
the level. Our study confirmed the correlation between the 
extension of the block and duration in 77% of patients, with 
a predictivity index of 59% and a P-value <0.05.
Denson et al (65) correlated the increased cephalic block 
extension with the concentration of CSF protein in diabetic, 
because of the closer protein link with anesthetics.
The concentration of CSF albumin influences the 
block’s outcome; although the protein binding reduces free 
anesthetic, it represents a reserve, which can be disposable 
afterwards.
As the Authors believe that CSF protein  increasing have 
no effect on the block level but can explain its prolonged 
duration (66,68), we found a negative correlation between 
maximum extension of the block and protein concentration 
in cerebrospinal fluid (rho = - 0.66), as well as between CSF 
protein  and onset to T10 (rho = - 0.81). The correlation betwe-
en recovery of sensitivity and CSF protein  is 58%.
The obvious differences between the results of our 
study and the other Authors one’s could be related to the 
local anesthetic used: ropivacaine in the present study and 
bupivacaine in all the others. So far, our study is the only 
one who has correlated glycorrhachia and CSF protein  with 
subarachnoid ropivacaine. The influence of the paramethers 
on block’s level and duration confirmed the hypothesis and 
can be the starting point for further studies on the use of 
intrathecal ropivacaine.
Conclusion
Hyperbaric anesthetics evidenced a better learning curve, 
determining a higher motor blockade and a quick onset; the 
iso-hypobaric one’s show a low cardiac and neurological 
toxicity, a high sensitive-motor dissociation, a suitable 
duration and an acceptably onset.
We observed the erratic behavior of intrathecal Ropi-
vacaine 0.5%, in patients undergoing surgery of TURP, 
although standardized position, level of injection, dose and 
concentration of local anesthetic.
While it has been written a lot about the characteristics 
of an ideal local anesthetic (69,70), much less was described 
about the ideal subarachnoid anesthesia. The predictability 
of a iso-hypobaric local anesthetic, could reduce the risk of 
procedure failure and adverse events by further cephalad 
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spread.
In literature the factors related to the technique (patient’s 
position - level block - needle tip direction - turbulence - 
barbottage - injection rate), the patient factors (age - weight 
- height -  BMI - spine’s anatomy), those related to the CSF 
characteristics (pressure, volume, density) and those related 
to the anesthetic’s characteristics (volume, density, concen-
tration, temperature) were evaluated.
These factors, were evaluated separately, thinking that 
each  parameter, by itself, could condition the outcome of 
the procedure.
 Few studies that considered these factors identified 
predictive criteria for adequate spinal anesthesia.
Surgery and personal practice particularly, influence 
spinal anesthesia technique, anesthetic’s choice and dose; 
the predictive result remains vague. After all, we considered 
ropivacaine a good choice for spinal anesthesia, overcoming 
the doubts of other Authors (71). With this study, we tried 
to identify a protocol for a subarachnoid block that could 
be simple, rapid and reproducible.
Still remaining the difficulties in obtaining the quality 
of sensory block, some criteria in predicting the intensity, 
extension and duration of the spinal anesthesia, by using 
Ropivacaine 0.5%, an iso-hypobaric local anesthetic, can 
be identified.
These factors can be listed as follows:
1. Injection level
The vertebral interspace cannot be too low, to avoid 
an insufficient spread of anesthetic. The block to L4 –L5 
interspace, may be insufficient for TURP surgery;
2. Administration rate of the local anesthetic
The administration rate should be moderately high, be-
cause of the influence on the cephalad block’s; interventions 
of  TURP includes metameric level analgesia between T8 
and T10.
3. Decubitus
The patient’s position and its duration represent an im-
portant parameter for iso-hypobaric anesthetics, affecting the 
onset time to the cephalic spread, conditioning the success 
or the procedure’s failure.
4. Temperature of the anesthetic
The local iso-hypobaric anesthetic cannot be stored in the 
refrigerator; temperatures below 24 ° C modifies the density, 
increasing it. A reduction of the cephalad anesthetic’s spread, 
when injected into a liquor to physiological temperature and 
density (37 ° C - 1003) occurs.
5. Dextrostix and stix urine.
  Glycorrhachia test by dextrostix, gives a quickly and 
reproducible CSF  glucose concentration. With a similar test, 
we used the  urine stick  for density and CSF protein. The 
acquisition of these parameters, although not incontestable 
in absolute, can be considered a suggestion, to decide rapi-
dly any reduction or increase in the anesthetic’s dose, the 
patient’s position and duration, etc, with reduction of undue 
or inadequate cephalad anesthetic’s spread.
In our opinion, glycorrhachia is a significant and fast 
index (5 seconds) and, with reasonable accuracy, can help to 
predict the onset time to T10 of ropivacaine, the maximum 
cephalad extension and the duration of the block, especially 
in diabetic patients.
In conclusion, we can say that the use of a iso-hypobaric 
local anesthetic is a valid and advantageous alternative. 
Though the spinal block’s extension is influenced by multiple 
factors, we believe that further parameters are ignored or 
underestimated in the daily clinical practice.
Ropivacaine 0.5% subarachnoid activity can be reaso-
nably anticipated, through easy and immediate evaluation 
of glycorrachia and CSF protein.
The time to test the result is acceptable (5 seconds for 
glicorrachia, 60 seconds for CSF protein), the “real time” 
dose optimization can help to predict spread and duration 
of sensory block, reducing unsatisfactory or adverse con-
sequences. 
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